A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).
about
Patients' rationale for declining participation in a cancer-associated weight loss study.The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer.Temporal Trends and Predictors for Cancer Clinical Trial Availability for Medically Underserved Populations.Patient income level and cancer clinical trial participation.Patient Income Level and Cancer Clinical Trial Participation: A Prospective Survey Study.Engaging older patients in cardiovascular research: observational analysis of the ICON-1 studyTreatment, Outcomes, and Clinical Trial Participation in Elderly Patients With Metastatic Pancreas Adenocarcinoma.Enhancing nurse contributions to SWOG clinical trials.Comparison of survival outcomes among cancer patients treated in and out of clinical trials.Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myelomaThe challenges of individualized care for older patients with localized breast cancer.Participation of the elderly population in clinical trials: barriers and solutions.Effect of medical oncologists' attitudes on accrual to clinical trials in a community setting.Examining Differences in Opportunity and Eligibility for Cancer Clinical Trial Participation Based on Sociodemographic and Disease Characteristics.Recruitment to the "Breast-Activity and Healthy Eating After Diagnosis" (B-AHEAD) Randomized Controlled Trial.Adjuvant chemotherapy in elderly patients with breast cancer: key challenges.Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527Representation of the elderly in trials of laparoscopic surgery for colorectal cancer.Cardio-oncology in the older adult.Breast cancer in the elderly: which lessons have we learned?Low-dose fludarabine with or without darbepoetin alfa in patients with chronic lymphocytic leukemia and comorbidity: primary results of the CLL9 trial of the German CLL Study Group.Barriers to Cancer Clinical Trial Participation Among Saudi Nationals: A Cross-Sectional Study.Pragmatic randomized clinical trials: a proposal to enhance evaluation of new cancer therapies with early signs of exceptional activity.Recruitment practices for U.S. minority and underserved populations in NRG oncology: Results of an online survey☆.Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review
P2860
Q33741114-46CFEDD0-D698-4E64-B713-A63FB7CF0F34Q33865329-2DF9D635-3A22-4EFB-AFF5-4EB78A91D1F9Q34209081-18890697-F29D-4698-91A7-091DE8BC25F8Q36064874-E959B560-879A-4BFE-92ED-1DE63FD9B4CAQ36589626-6159FE50-ED16-46B6-A249-0E68CB8BD31DQ36775901-487F17A8-3A7C-466F-ADD7-0558469F01FEQ37156451-F60B0C4F-26AE-4789-BD39-B60571EC2845Q37168250-F9A5C009-A01A-4860-9ACB-C0224F869E6DQ37651986-33A690E8-F72F-4CFA-8C46-4A16C0B0AEF4Q37696455-549B4646-A55B-490F-A2EB-A0C9284EBFD8Q37744801-69F847DD-E678-4C1E-A7A7-A91A236095BCQ38132244-C92E23CD-4995-422D-891F-8061718B684AQ38222467-C5DD6E9D-21D1-46C0-9BEC-4235349DEAADQ38403698-4D5786DB-82F2-4119-9917-D7499D1627BCQ38672517-D2E37550-C2F8-43E7-BC91-6AE8AA290493Q38767362-3E261E1C-0354-4BA5-8F79-41AC84ABB417Q38787215-236EA4B1-0D4B-44E3-9A5D-8D37EEB792A3Q39089103-298992C1-FF7C-4CB1-BA63-8FF3AEED2DB9Q39110238-8330A780-A01F-46C4-A92D-608470078E98Q39303131-0B27BA07-8577-41E9-ABBF-3941FEEFE187Q39303318-DE117761-03A3-468D-923F-DBD7ACBF6B97Q41041090-F18AC369-8D2E-413E-96CF-1FBF1AC30D77Q47686048-D792CC53-C1AC-44B4-8B19-4F1F2EB500A3Q52854327-2922CA3D-0909-49C9-BB4F-C411697540BBQ55712411-2D3B8FEB-2A84-40C7-B50B-229CC1A2029AQ58797089-FC280077-9AF3-49CB-81E3-4E064FF8FCA9
P2860
A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A prospective analysis of the ...... clinical trials (SWOG S0316).
@ast
A prospective analysis of the ...... clinical trials (SWOG S0316).
@en
type
label
A prospective analysis of the ...... clinical trials (SWOG S0316).
@ast
A prospective analysis of the ...... clinical trials (SWOG S0316).
@en
prefLabel
A prospective analysis of the ...... clinical trials (SWOG S0316).
@ast
A prospective analysis of the ...... clinical trials (SWOG S0316).
@en
P2093
P2860
P1433
P1476
A prospective analysis of the ...... clinical trials (SWOG S0316).
@en
P2093
Antoinette J Wozniak
Carol M Moinpour
Carolyn C Gotay
J Wendall Goodwin
Joseph M Unger
Julie R Gralow
Kathy S Albain
Laura F Hutchins
Pamela A Williams
Primo N Lara
P2860
P304
P356
10.1634/THEONCOLOGIST.2011-0384
P577
2012-06-20T00:00:00Z